C000232435 Performance — Direxion mRNA ETF
Data updated: 2023-06-29
C000232435 returned −0.97% over one year to Apr 2023. Over one year the fund trailed its Europe Equity category average: $100 grew to $99, against $107 for the category. Volatility over the past 12 months was 22.05% a year. In the 12 months to Apr 2023 the fund took in a net $7.4M, and assets reached $126K.
C000232435 Growth of $100
What $100 invested in Direxion mRNA ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Europe Equity category average over the same months.
| Period | C000232435 | Category average |
|---|---|---|
| 1 year (May 2022 – Apr 2023) | $99 | $107 |
| Since data start (Dec 2021 – Apr 2023) | $57 | $94 |
C000232435 Trailing Returns
Total returns to Apr 2023, from SEC N-PORT.
| Period | Total return |
|---|---|
| 1 year | −0.97% |
C000232435 Annual Returns
Calendar-year total returns of Direxion mRNA ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2023 (Jan–Apr) | +0.07% |
| 2022 | −39.72% |
| 2021 (Dec–Dec) | −5.44% |
C000232435 Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | +11.9% | −11.8% | −2.9% | +4.4% | — | — | — | — | — | — | — | — |
| 2022 | −22.6% | −0.7% | −2.4% | −18.8% | −5.3% | −0.6% | +6.1% | +0.8% | −6.6% | +4.9% | −0.7% | +1.1% |
| 2021 | — | — | — | — | — | — | — | — | — | — | — | −5.4% |
C000232435 Risk
Risk measures from monthly returns over May 2022 – Apr 2023.
- 1-year volatility (annualised): 22.05%
- Best month: +11.93% (Jan 2023)
- Worst month: −11.79% (Feb 2023)
C000232435 Fund Flows
Monthly money in and out of Direxion mRNA ETF, from SEC Form N-PORT.
- 12-month net flow: $7.4M
- 12-month gross sales (incl. reinvestments): $2.1M
- Sales ÷ redemptions: -0.41×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Apr 2023 | $0 | −$3.0M | $3.0M |
| Mar 2023 | $339K | $0 | $339K |
| Feb 2023 | $0 | −$1.1M | $1.1M |
| Jan 2023 | $0 | −$386K | $386K |
| Dec 2022 | $1.5M | −$370K | $1.8M |
| Nov 2022 | $0 | −$357K | $357K |
| Oct 2022 | $0 | $0 | $0 |
| Sep 2022 | $0 | $0 | $0 |
| Aug 2022 | $0 | $0 | $0 |
| Jul 2022 | $0 | $0 | $0 |
| Jun 2022 | $331K | $0 | $331K |
| May 2022 | $0 | $0 | $0 |
C000232435 Assets Under Management
Net assets of Direxion mRNA ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2023-04-30 | $126.22K |
| 2023-01-31 | $4.39M |
| 2022-10-31 | $3.55M |
| 2022-07-31 | $3.60M |
| 2022-04-30 | $3.24M |
| 2022-01-31 | $3.20M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.